Shelter Pharma quarterly results and financials

Shelter Pharma (BSE 543963)₹45.00−4.26%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Shelter Pharma reported sales of ₹39.68 Cr, up 49.8% from Mar 2025, and net profit of ₹4.51 Cr, up 22.2% year on year. For the year to Mar 2026, sales were ₹72.84 Cr and net profit ₹8.99 Cr.

Sales (Mar 2026): ₹39.68 Cr
Net profit (Mar 2026): ₹4.51 Cr
Sales (FY Mar 2026): ₹72.84 Cr
Net profit (FY Mar 2026): ₹8.99 Cr
EPS (Mar 2026): ₹2.72
Borrowings (Mar 2026): ₹0.79 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Shelter Pharma quarterly results

₹ crore unless stated; each column is a quarter.

Shelter Pharma Quarterly results
	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	19.06	19.25	20.64	23.98	26.49	33.18	39.68
Expenses	14.85	15.06	16.44	19.21	21.47	27.08	33.45
Operating Profit	4.30	4.28	4.27	4.88	5.16	6.23	6.45
OPM %	22.6%	22.3%	20.7%	20.4%	19.5%	18.8%	16.3%
Other Income	−0.44	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.02	0.06	0.00	0.08	0.07	0.07	0.06
Depreciation	0.09	0.13	0.14	0.11	0.18	0.20	0.23
Profit before tax	3.78	4.13	4.17	4.74	4.96	6.02	6.22
Tax %	25.5%	24.8%	25.0%	25.2%	25.1%	25.3%	27.1%
Exceptional items	−0.35	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	2.80	3.09	3.11	3.52	3.69	4.48	4.51
EPS (Rs)	3.64	2.67	2.69	3.05	3.19	3.88	2.72

Shelter Pharma profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Shelter Pharma Profit and loss
	Mar 2016	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	27.99	29.86	29.95	22.40	29.93	36.02	39.79	50.44	72.84
Expenses	27.97	30.70	29.87	22.34	27.05	28.06	31.18	40.67	60.55
Operating Profit	0.14	−0.69	0.23	0.18	3.04	8.12	8.76	10.03	12.68
OPM %	0.5%	−2.3%	0.8%	0.9%	10.2%	22.6%	22.0%	19.9%	17.4%
Other Income	0.00	0.82	0.00	0.00	0.00	−0.96	0.00	0.00	0.01
Interest	0.00	0.00	0.02	0.03	0.09	0.04	0.27	0.14	0.12
Depreciation	0.11	0.08	0.14	0.13	0.18	0.17	0.26	0.28	0.42
Profit before tax	0.06	0.07	0.12	0.07	2.81	7.00	8.29	9.69	12.24
Tax %	20.0%	16.7%	27.3%	33.4%	26.8%	25.5%	25.1%	25.2%	26.2%
Exceptional items	0.00	0.00	0.00	0.00	0.00	−0.73	0.00	0.00	0.00
Net Profit	0.04	0.04	0.07	0.03	2.05	5.19	6.18	7.21	8.99
EPS (Rs)	1.11	1.09	1.75	0.82	42.54	6.74	5.35	6.25	5.43
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Shelter Pharma balance sheet

₹ crore, at each year end.

Shelter Pharma Balance sheet
	Mar 2016	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.44	0.44	0.44	0.47	0.49	7.72	11.52	11.53	16.55
Reserves	7.30	7.32	6.54	6.64	8.31	6.80	24.18	31.09	59.83
Borrowings	2.06	0.10	0.23	0.00	0.12	1.77	0.57	1.03	0.79
Other Liabilities	1.72	3.74	3.39	3.08	3.89	5.09	1.51	4.56	6.77
Total Liabilities	11.52	11.60	10.60	10.19	12.81	21.38	37.78	48.21	83.94
Fixed Assets	2.62	2.72	1.78	1.58	1.46	2.53	4.27	6.65	7.15
CWIP	0.13	0.10	0.00	0.00	0.54	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.67	0.69	0.69	0.00	0.00	0.00	0.69
Other Assets	8.77	8.78	8.15	7.92	10.12	18.85	33.51	41.56	76.10
Inventories	4.42	3.90	4.30	4.01	5.66	7.95	9.92	12.87	24.39
Trade receivables	0.99	1.15	0.60	0.75	1.60	8.17	8.83	9.44	11.78
Cash & equivalents	0.11	0.09	0.13	0.36	0.09	0.42	5.05	3.41	1.07
Total Assets	11.52	11.60	10.60	10.19	12.81	21.38	37.78	48.21	83.94

Shelter Pharma cash flow

₹ crore, for each year.

Shelter Pharma Cash flow
	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−0.28	−0.29	0.53	0.00	−1.97	5.49	−12.52
Cash from investing activity	0.28	0.02	−0.84	0.10	−4.42	−7.11	−14.52
Cash from financing activity	0.00	0.49	0.07	0.22	11.04	0.04	24.79
Net cash flow	0.01	0.22	−0.26	0.32	4.60	−1.61	−2.33
Capex	0.04	0.00	0.59	0.00	0.84	2.64	1.58
Free cash flow	−0.33	−0.30	−0.09	0.00	−2.82	2.84	−14.13
CFO / OP %	−112.0%	−147.0%	17.0%	0.0%	−5.0%	79.0%	−73.0%

Shelter Pharma ratios

Working-capital days and returns, by year.

Shelter Pharma Ratios
	Mar 2016	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	13	14	7	12	20	83	81	68	59
Inventory days	62	51	57	70	81	112	126	128	162
Days payable	3	3	4	6	6	8	10	13	9
Cash conversion cycle	72	62	60	76	95	187	197	183	211
Working capital days	91	60	54	75	72	122	212	182	234
ROCE %	—	0.7%	—	1.1%	35.9%	63.3%	32.4%	24.5%	20.4%

Shelter Pharma: frequently asked questions

What are the latest quarterly results of Shelter Pharma?

For the Mar 2026 quarter, Shelter Pharma reported sales of ₹39.68 Cr, up 49.8% year on year and net profit of ₹4.51 Cr, up 22.2% year on year. The operating margin was 16.3%.

What is the annual revenue of Shelter Pharma?

Shelter Pharma's sales for the year to Mar 2026 were ₹72.84 Cr.

What is the net profit of Shelter Pharma?

Net profit for the year to Mar 2026 was ₹8.99 Cr. Earnings per share over the same trailing period were ₹5.43.

How much debt does Shelter Pharma have?

Shelter Pharma reported borrowings of ₹0.79 Cr at Mar 2026, against cash and equivalents of ₹1.07 Cr.

What is the free cash flow of Shelter Pharma?

Cash from operations was −₹12.52 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹14.13 Cr.

Loading…